Table 1.
Activity (preferential for) | Human | Rat | Mouse | Guinea pig | Pig |
---|---|---|---|---|---|
AHH (CYP1 family) | 0.24–1.35a | 1.25 ± 0.11a | mb: 3.3–8a; fb: 17–21a | 2.51 ± 0.35a | |
EROD (CYP1 family) | bd–35a | m: 3.6 ± 0.3; f: 1.5 ± 0.2a | m: bd; f: 3–19a | 4.62 ± 0.54b | |
ECOD (CYP1A, 2B) | bd–12a | 0.36–2.15a | 10.4–80a | 3.8 ± 2.7a | (13.2 ± 2.5b) |
MROD (CYP1A2) | bd to + | ||||
PROD (CYP2B) | bd to bq | m: 3.7 ± 1.3; f: 1.8 ± 0.1a | m: bq; f: 0.1–1.7a | bq | bd |
BROD (CYP3A, 2B) | m: 4.4 ± 0.9; f: 2.1 ± 0.2a | ||||
Aminopyrine-N-demethylase (CYP2B, 3A) | 1,000–4200a | + | |||
Tolbutamide 4-hydroxylation (CYP2C9) | 0.46 ± 0.05b | 0.47 ± 0.04b | bd | 1.66 ± 0.49b | |
Bufuralol 1-hydroxylation (CYP2D6) | bd | 1.33 ± 0.17b | 9.23 ± 0.67b | 0.26 ± 0.03b | |
Chlorzoxazone 6-hydroxylation (CYP2E1) | 2.83 ± 0.34b | bd | 20.8 ± 0.5b | bd | |
Para-nitrophenol hydroxylation (CYP2E1) | bd/+ | bdc | f: 40 ± 10a | ||
Midazolam 1-hydroxylation (CYP3A) | 2.35 ± 0.23b | 0.58 ± 0.09b | 8.70 ± 0.28b | 2.32 ± 0.21b | |
Benzoquinoline O-dealkylation (CYP3A) | bd–76 ± 41a | ||||
Erythromycin N-demethylation (CYP3A) | + | bd–270a | f: 540–1100a |
More examples and references in the text
AHH aryl hydrocarbon hydroxylase, phenolic benzo[a]pyrene metabolites determined with 3-hydroxy-benzo[a]pyrene as standard, bd below detection, BROD 7-benzyloxyresorufin O-debenzylase, bq below quantification, ECOD 7-ethoxycoumarin O-deethylase, EROD 7-ethoxyresorufin O-deethylase, f female, m male, MROD 7-methoxyresorufin O-demethylase, PROD pentoxyresorufin O-depentylase
apmol/mg protein/min
bpmol/mg protein/h, numbers in brackets: in medium of short-term culture
cIn epidermal microsomes